Pharmaceuticals
News Releases
2013
December
November
Pharmaceuticals
CHMP Recommends Otsuka's Deltyba™ (delamanid) for EU Approval for Treatment of Multidrug-Resistant Tuberculosis (MDR-TB) in Combination with Optimized Background Regimen (OBR)
Nutraceuticals
New From the US, A Smart New Way to Take Vitamin and Mineral Supplements VitaMelts® Dissolve Smoothly Without Water Available at Convenience Stores Throughout Japan From November 25
Pharmaceuticals
Otsuka and Lundbeck's Once-Monthly Abilify Maintena® (Aripiprazole) Now Approved in Europe for Maintenance Treatment of Schizophrenia in Adult Patients Stabilized with Oral Aripiprazole
Corporate
Otsuka Co-sponsors the Fifth Annual Asan Walking Festival in Itano on November 10
October
Pharmaceuticals
Otsuka Named as Lundbeck's Partner in Japan on Nalmefene for the Reduction of Alcohol Consumption
Nutraceuticals
Get the Dietary Fiber That is Missing From Your Diet*1With a Healthy Combination of Cereal Grains Otsuka Launches the New Products "Gerblé Multicereal Chocolate" and "Gerblé Multicereal Apricot"
Pharmaceuticals
Lundbeck and Otsuka Initiate Phase III Clinical Trials on Lu AE58054 as a New Add-On Treatment for Alzheimer's Disease
Pharmaceuticals
Otsuka Pharmaceutical Receives the 2013 Good Design Award for the Antiplatelet Drug "Pletaal® OD Tablets"
September
Pharmaceuticals
Otsuka And Lundbeck Receive Postive Chmp Opinion In Europe For Abilify Maintena™, A Once-Monthly Injectable For Schizophrenia
Nutraceuticals
Two New Flavors of SoyCarat Nori & Natto and Olive Oil & Garlic Flavors Debut October 2
Pharmaceuticals
Vasopressin V2 Receptor Antagonist Samsca®7.5mg Tablets Granted Additional Indication in Japan for the Treatment of Fluid Retention in Patients with Hepatic Cirrhosis
Nutraceuticals
UL•OS Line of Men's Skin Care Marks 5th Anniversary Now Effective in Minimizing the Appearance of Fine Lines and Wrinkles Caused by Dryness
Corporate
Otsuka Pharmaceutical to Acquire Astex Pharmaceuticals
August
Pharmaceuticals
Otsuka Receives Complete Response Letter From U.S. Food And Drug Administration For Tolvaptan For Use In Patients With Autosomal Dominant Polycystic Kidney Disease
Pharmaceuticals
Japan's First Dry Syrup Formulation of an Anti-epileptic Drug for the Treatment of Partial-onset Seizures, E Keppra® Dry Syrup 50%, to Be Launched on August 29
Nutraceuticals
On September 1, Otsuka Launches "Omugi Seikatsu," a Healthy Breakfast Food With Barley Beta-Glucans
Pharmaceuticals
U.S. Food and Drug Administration's Cardiovascular and Renal Drugs Advisory Committee Recommends Against Approval of Otsuka Pharmaceutical's Tolvaptan for Use in Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Pharmaceuticals
Fingraph®, a fingertip blood sampler that conveniently measures sodium and potassium electrolyes in just one minute, debuts in Japan on August 6
Corporate
Come Check Out Our Brand New English Site! Global Website for Global Company Launches on Aug 1, 2013 http://www.otsuka.co.jp/en
July
Pharmaceuticals
Otsuka Receives Opinion from CHMP on Delamanid
Pharmaceuticals
Phase II clinical data show statistically significant improvement for Lu AE58054 as add-on to donepezil, versus donepezil alone, on cognitive symptoms of Alzheimer's disease*1 Lundbeck and Otsuka present data at Alzheimer’s Association International Conference 2013
Nutraceuticals
A Heat Wave Is Coming - Protect Yourself From Heat Stroke Otsuka's New "Heat Stroke Prevention Information" Service Launches July 8 Receive Automatic Updates on a "Heat Index" Indicating Your Heat Stroke Risk Level
Pharmaceuticals
Otsuka Europe Development and Commercialisation Ltd., a New Company for the Development of Pharmaceuticals Opens in the UK
June
Pharmaceuticals
Two New Formulations of E Keppra® Developed Dry Syrup Obtains Approval; Application Filed for Injectable Formulation Address various needs of patients with epilepsy from 4 years of age and contribute to improvement of compliance with medication
Pharmaceuticals
A New Choice of Therapy for the Treatment of Depression:ABILIFY® Granted Additional Approval as Adjunctive Therapy for the Treatment of Depression in Japan
Nutraceuticals
The No.1 pharmacist-recommended supplement*1「Nature Made」The First Supplement Facility was Built in Alabama*2.Production Capacity Increases 40% by 2014
Corporate
Otsuka has been selected by METI as a model enterprise for business continuity management
Pharmaceuticals
Otsuka Pharmaceutical Submits New Drug Application in Japan for Tolvaptan for the Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Pharmaceuticals
Vasopressin V2 Receptor Antagonist Samsca® 7.5mg Tablets To Be Launched in Japan on June 4 - Additional Choice of Dose for the Treatment of Volume Overload in Patients with Heart Failure
May
Pharmaceuticals
Antiepileptic Drug E Keppra® Tablet Approved in Japan for Pediatric Epilepsy (Partial-Onset Seizures)
Pharmaceuticals
Study Shows Effects of Treatment with ABILIFY MAINTENA™ (Aripiprazole) on Psychiatric Hospitalization Rates for Patients with Schizophrenia
Pharmaceuticals
Acucela and Otsuka Pharmaceutical Announce Phase IIa Clinical Results of Emixustat Hydrochloride (ACU-4429) in Patients with Geographic Atrophy (GA) Associated with Dry Age-related Macular Degeneration (AMD) at ARVO 2013 Annual Meeting
April
Pharmaceuticals
Otsuka Pharmaceutical's 44-member Employee Dance Group "Otsuka-Ren" Presented Traditional "Awa-Odori" of Tokushima, Where the Company Originates From, At Copenhagen Sakura Festival Held in Denmark
Pharmaceuticals
"Epi Diary" - An Epilepsy Diary Application for iOS A New Communication Tool for Patients with Epilepsy and their Physicians Now Available at https://itunes.apple.com/app/epi-diary/id616736809?Is=1&mt=8
Pharmaceuticals
Otsuka's New Drug Application For Tolvaptan, An Investigational Compound For Autosomal Dominant Polycystic Kidney Disease (ADPKD), Accepted For Review By The US Food And Drug Administration (FDA)
Nutraceuticals
New Version of POCARI SWEAT Low calorie beverage with subtle sweetness, refreshing after-taste POCARI SWEAT ION WATER Debuts April 8, 2013
Corporate
Like Having Everything At Your Fingertips? Then Check This Out! Otsuka Pharmaceutical Announces A Revamped Website April 1, 2013 http://www.otsuka.co.jp/
March
Pharmaceuticals
Otsuka's Novel Treatment for Multidrug-Resistant Tuberculosis, Delamanid, Submitted For Regulatory Approval in Japan -- Half Century Since Last Drug Was Approved in Japan for Tuberculosis
Pharmaceuticals
Lundbeck and Otsuka Further Expand Alliance and Enter Into Collaboration For the Development and Commercialization of Lu AE58054 In Development For Alzheimer's Disease
Pharmaceuticals
Otsuka Obtains Marketing Approval in Japan for Onglyza® Tablets to Treat Type 2 Diabetes; Transferred Rights to Kyowa Hakko Kirin
Nutraceuticals
"Weight Management with Chocolate" White Chocolate and Orange Chocolate Gerlinéa Meal Replacement Bars Debut on March 18
Nutraceuticals
The Healthy Benefits of Whole Soy Flavored with Crunchy Peanuts SOYJOY Peanuts Debuts April 24
Pharmaceuticals
Otsuka Advancing Rapidly in Central Nervous System Disorders; Expanding Its Existing Collaboration with Lundbeck
Pharmaceuticals
FDA Approves Once-Monthly ABILIFY MAINTENA™ (Aripiprazole) For Extended-Release Injectable Suspension for the Treatment of Schizophrenia
February
Pharmaceuticals
The First Transdermal Dopamin Agonist in Japan Neupro® Patch, For Both Parkinson's Disease and Restless Legs Syndrome, To Be Launched on February 26
Pharmaceuticals
L-Cartin® FF oral solution 10% and L-Cartin® FF injection 1000mg Two New Drug Forms for Carnitine Deficiency To Be Launched on February 26
Nutraceuticals
Otsuka Pharmaceutical Contributes to the Success and Development of the Tokyo Marathon as a Total Health Care Company Supporting Safe Running and Encouraging Runners to Complete the Full Distance with Amino Acids, Fluids and Electrolytes
Pharmaceuticals
7.5mg Tablets Additionally Approved - Samsca®, Vasopressin V2 Receptor Antagonist
Pharmaceuticals
The European Medicines Agency (EMA) Approves Aripiprazole (ABILIFY®) for the Treatment of Moderate to Severe Manic Episodes in Bipolar I Disorder in Adolescents.
January
Nutraceuticals
UL･OS Line of Men's Skincare Launches New SPF 50 & SPF 25 Sunscreens Applies Smoothly, Leaves No White Residue
Pharmaceuticals
Otsuka Pharmaceutical Files for Application of New Dry Powder Inhaler Product from the Meptin Brand
Nutraceuticals